Givaudan | GIVN - Cash And Equivalent

Stock Price
3,088.00
Daily Change
5.00 0.16%
Monthly
-1.03%
Yearly
-19.79%
Q1 Forecast
2,915.39

Givaudan reported CHF603M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Air Liquide EUR 1.92B 0 Jun/2025
Akzo Nobel EUR 1.55B 47M Jun/2025
Anheuser-Busch USD 7.06B 4.11B Jun/2025
Arkema EUR 1.31B 193M Jun/2025
Associated British Foods GBP 758M 1.36B Dec/2024
BASF EUR 1.86B 658M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
British American Tobacco GBP 5.93B 1.28B Jun/2024
Covestro EUR 604M 115M Sep/2025
Croda International GBP 157.8M 9M Jun/2025
Danone EUR 1.62B 144M Jun/2025
Diageo GBP 2.2B 544M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.26B 459.13M Sep/2025
Givaudan CHF 603M 3M Jun/2024
Glanbia EUR 417M 116.1M Jan/2025
Heineken EUR 2.07B 284M Jun/2025
International Flavors Fragrances USD 621M 195M Sep/2025
Johnson Matthey GBP 542M 49M Jun/2024
Lonza CHF 1.11B 286M Dec/2024
L'Oréal EUR 4.82B 769.6M Jun/2025
Merck EUR 1.17B 161M Jun/2025
Nestle CHF 4.65B 904M Jun/2025
Pernod Ricard EUR 1.94B 748M Dec/2024
Reckitt Benckiser GBP 880M 106M Dec/2024
SGS CHF 1.21B 78M Dec/2024
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 410M 77M Sep/2025
Tate & Lyle GBP 475M 41M Jun/2023
Umicore EUR 2.01B 712.6M Dec/2024
Victrex GBP 58.7M 13M Dec/2022